Showing results (21-30 of 70) with videos related to

Sort By:
Pageof 7
Cancer Prevention Research (Philadelphia, Pa.)|August 25, 2021
Vaccination with Polyclonal Antibody Stimulator (PAS) Prevents Pancreatic Carcinogenesis in the KRAS Mouse ModelJill P Smith, Hong Cao, Wenqiang Chen, et al.
International Journal of Molecular Medicine|November 14, 2002
Characterization of the CCK-C (cancer) receptor in human pancreatic cancerJill P Smith, Michael F Verderame, Patricia McLaughlin, et al.
Biomolecules|December 24, 2021
Cholecystokinin-B Receptor-Targeted Nanoparticle for Imaging and Detection of Precancerous Lesions in the PancreasJill P Smith, Hong Cao, Elijah F Edmondson, et al.
Clinical and Translational Gastroenterology|January 8, 2016
Germline Mutation of the CCK Receptor: A Novel Biomarker for Pancreas CancerJelal Alsubai, Gail L Matters, Christopher O McGovern, et al.
International Journal of Molecular Sciences|December 11, 2025
Downregulation of the CCK-B Receptor in Pancreatic Stellate Cells Blocks Molecular Proliferative Pathways and Increases Apoptosis to Decrease Pancreatic Cancer Growth In VitroMiranda Ortega, Eri Agena, Wenqiang Chen, et al.
Comparative Medicine|January 24, 2020
Role of the δ-Opioid Receptor in 2 Murine Models of ColitisTia R Bobo, Leo R Fitzpatrick, Tiffany L Whitcomb, et al.
Journal of Immunotoxicology|June 24, 2008
The opioid antagonist naltrexone improves murine inflammatory bowel diseaseGail L Matters, John F Harms, Christopher McGovern, et al.
Open Access Journal of Clinical Trials|October 5, 2010
Opioid growth factor improves clinical benefit and survival in patients with advanced pancreatic cancerJill P Smith, Sandra I Bingaman, David T Mauger, et al.
International Journal of Molecular Sciences|February 15, 2022
Proglumide Reverses Nonalcoholic Steatohepatitis by Interaction with the Farnesoid X Receptor and Altering the MicrobiomeMartha D Gay, Hong Cao, Narayan Shivapurkar, et al.
Pharmaceutics|March 28, 2026
Effects of Proglumide with Chemotherapy on the Pancreatic Tumor Microenvironment: Phase 1 PROGEM TrialJill P Smith, Gakiza C Nkulikiyimana, Hong Cao, et al.
Pageof 7